Max Higgins, Consultant, Author at EverGlade Consulting

Max Higgins, Consultant

Max Higgins, Consultant
ARPA-H ADVOCATE Program

ARPA-H Launches ADVOCATE to Transform Cardiovascular Care with Agentic AI

ARPA-H-SOL-26-142_ADVOCATE+ISO ARPA-H Launches ADVOCATE to Transform Cardiovascular Care with Agentic AI The Advanced Research Projects Agency for Health (ARPA-H) has released a new Innovative Solutions Opening (ISO), Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE), aimed at fundamentally modernizing how chronic cardiovascular disease (CVD) is managed in the United States. Announced by ARPA-H’s Scalable Solutions Office (SSO), […]

ARPA-H Launches ADVOCATE to Transform Cardiovascular Care with Agentic AI Read More »

ASPR’s Strategic Plan for FY 2026-2029

Dowload ASPR Strategic Plan FY 2026-2029 The Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) has released its Strategic Plan for Fiscal Years (FY) 2026–2029, setting a clear direction for the federal government’s approach to health security. As the nation’s lead health security agency, ASPR is responsible for preparing

ASPR’s Strategic Plan for FY 2026-2029 Read More »

DARPA MARRS to Advance Solid-State Fusion at Room Temperature

DARPA Launches MARRS to Advance Solid-State Fusion at Room Temperature

Broad Agency Announcement: MARRS HR001126S0007 The Defense Advanced Research Projects Agency (DARPA) has released a new Broad Agency Announcement (BAA) under its Defense Sciences Office (DSO) titled Mechanisms for Amplification of Fusion Reaction Rates in Solids (MARRS). Through MARRS, DARPA seeks to explore whether nuclear fusion reactions operating at or near room temperature in solid

DARPA Launches MARRS to Advance Solid-State Fusion at Room Temperature Read More »

DARPA’s Generative Optogenetics (GO) Program

DARPA’s Generative Optogenetics (GO) Program

DARPA-PS-26-10 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released a new program solicitation for Generative Optogenetics (GO), a bold, high-risk, high-reward research effort aimed at redefining how genetic information is delivered to living cells. Announced on December 19, 2025, this solicitation reflects DARPA’s continued investment in foundational biological

DARPA’s Generative Optogenetics (GO) Program Read More »

ARPA-H BioStabilization Systems (BoSS) Program

ARPA-H Launches the BioStabilization Systems (BoSS) Program to Transform Cell Therapy Distribution

BOSS_ISO_Final_01Dec2025 The Advanced Research Projects Agency for Health (ARPA-H) has announced a landmark Innovative Solutions Opening (ISO) for the BioStabilization Systems (BoSS) program, an ambitious effort to revolutionize how live cell-based therapies are stabilized, manufactured, and distributed. As outlined in the solicitation, BoSS aims to eliminate the field’s dependence on ultra-cold storage and transport, which

ARPA-H Launches the BioStabilization Systems (BoSS) Program to Transform Cell Therapy Distribution Read More »

DARPA BAA Information Innovation

DARPA I2O Office-Wide BAA Opens the Door for Breakthroughs in Information Innovation

DARPA Broad Agency Announcement HR001126S0001 The Defense Advanced Research Projects Agency (DARPA), through its Information Innovation Office (I2O), has released its FY2026 Office-Wide Broad Agency Announcement (BAA) seeking groundbreaking research that can fundamentally reshape the nation’s capabilities across information science, cybersecurity, artificial intelligence (AI), and complex software systems. This solicitation, HR001126S0001, invites performers to propose

DARPA I2O Office-Wide BAA Opens the Door for Breakthroughs in Information Innovation Read More »

BARDA next generation vaccine platforms

BARDA Seeks Next-Generation Vaccine Platforms to Accelerate National Preparedness

New-Vaccine-Platforms-RFI_Amd-1.pdf The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), has released a new Request for Information (RFI) focused on “New Vaccine Platforms.” This solicitation seeks to better understand the current landscape of vaccine platform technologies

BARDA Seeks Next-Generation Vaccine Platforms to Accelerate National Preparedness Read More »

ARPA-H Evident Program

ARPA-H’s EVIDENT Program to Transform Behavioral Health Intervention Research

ARPA-H-RFS-EVIDENT-TA-1-3-Exploratory_Clean ARPA-H’s EVIDENT Program Seeks Objective Clinical Endpoints for Rapid-Acting Behavioral Health Treatments (1) Mental and behavioral health disorders, including depression, anxiety, and addiction, affect about half of all Americans, with treatment costs nearing $200 billion annually.  Yet, traditional diagnostics still rely heavily on subjective endpoints that fail to capture the complexity and immediacy of

ARPA-H’s EVIDENT Program to Transform Behavioral Health Intervention Research Read More »

JPEO seeks next-generation genomic sequencing

JPEO-CBRND Seeks Next-Generation Genomic Sequencing for Defense Readiness

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has released a new Request for Information (RFI) focused on advancing end-to-end, untargeted genomic sequencing workflows for military use. As the Department of Defense (DoD) increases its emphasis on rapid biodefense decision-making, this RFI highlights the agency’s commitment to identifying technologies capable

JPEO-CBRND Seeks Next-Generation Genomic Sequencing for Defense Readiness Read More »

JPEO Innovation Biologics Manufacturing

JPEO-CBRND Seeks Innovation in Biologics Manufacturing

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has released a new Request for Information (RFI) focused on Innovation in Biologics Manufacturing, underscoring the organization’s mission to strengthen U.S. biodefense through next-generation bioproduction capabilities. As the premier program management office for enabling biotechnologies across the War Department, JPEO-CBRND aims to

JPEO-CBRND Seeks Innovation in Biologics Manufacturing Read More »

ARPA-H AIR

EverGlade Insights: ARPA-H Launches the Autonomous Interventions and Robotics (AIR) Program

AIR+ARPA-H-SOL-26-146+Amend+01 The Advanced Research Projects Agency for Health (ARPA-H) has released a major new Innovative Solutions Opening (ISO) titled Autonomous Interventions and Robotics (AIR), marking one of the most ambitious federal investments to date in autonomous surgical systems and micro-scale medical robotics. The program seeks to fundamentally redefine how clinicians diagnose and treat life-threatening conditions

EverGlade Insights: ARPA-H Launches the Autonomous Interventions and Robotics (AIR) Program Read More »

JPEO RFI for Faster CBRN Medical Countermeasures

JPEO-CBRND’s New Approach Methods RFI for Faster CBRN Medical Countermeasures

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense – Enabling Biotechnologies (JPEO-CBRND-EB) has released a Request for Information (RFI) on New Approach Methods (NAMs) to support medical countermeasure (MCM) development against chemical, biological, radiological, and nuclear (CBRN) threats. In line with broader efforts at the Food and Drug Administration (FDA) and

JPEO-CBRND’s New Approach Methods RFI for Faster CBRN Medical Countermeasures Read More »

Scroll to Top